Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|May 6, 1989
Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortalityM Tersmette, J M Lange, R E de Goede, et al.
Annals of Internal Medicine|August 7, 2001
The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trialH W Eijkhout, J W van Der Meer, C G Kallenberg, et al.
Nature Medicine|February 14, 1998
Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferationN G Pakker, D W Notermans, R J de Boer, et al.
The Journal of Infectious Diseases|September 9, 1999
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adultsD W Notermans, N G Pakker, D Hamann, et al.
AIDS (London, England)|April 1, 1996
Complications of varicella zoster virus reactivation in HIV-infected homosexual menJ Veenstra, R M van Praag, A Krol, et al.
The Journal of Infectious Diseases|February 10, 1999
Expression of granzyme B during primary cytomegalovirus infection after renal transplantationP C Wever, L H Spaeny, H J van der Vliet, et al.
Journal of the American Academy of Dermatology|November 26, 1999
Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis)D N Enomoto, J R Mekkes, P M Bossuyt, et al.
Blood|December 1, 1994
Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiencyJ E van Leeuwen, M J van Tol, A M Joosten, et al.
AIDS (London, England)|December 22, 1999
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapyJ M Prins, S Jurriaans, R M van Praag, et al.
Journal of Clinical Immunology|June 14, 2001
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletionR M van Praag, J M Prins, M T Roos, et al.
Pageof 12